301033: Medprin Regenerative Medical Technologies Co., Ltd. - Summary | Jitta

Medprin Regenerative Medical Technologies Co., Ltd.

CHN:301033

Price
CN¥56.82
Loss Chance
41.0%
7.42JITTA SCORE
7.69%Under Jitta Line
Jitta Ranking
12 / 486
102 / 5,274
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (74)
Recent Business Performance (77)
Financial Strength (90)
Return to Shareholders (50)
Competitive Advantage (71)
Jitta Signs
Revenue and EarningConsistent High Growth in the past 5 years
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
SG&A to SalesDecreasing
Key Stats
Jitta Score
Jitta Line
7.42
7.69%
4.24
> 1,000%
Health Care Equipment
6.71
31.91%
5.78
74.94%
5.90
89.85%
COMPANY DESCRIPTION
Medprin Regenerative Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of implantable medical devices in China and internationally. The company offers artificial dura mater patches, craniofacial repair and fixation systems, and absorbable regenerative oxidation for neurosurgery meningeal repair, skull repair fixation and rapid hemostasis, etc. It also offers ReDura, a Synthetic Dural Substitute; NeoDura, a novel dural patch; Recranio, a Cranio-Maxillofacial repair system; and StypCel, an Absorbable Hemostat; Immiseal, a dural sealant system; and 3D bioprinting applications serving patients internationally. Medprin Regenerative Medical Technologies Co., Ltd. was founded in 2008 and is headquartered in Guangzhou, China.